My site

 ProSiebenSat.1 renews distribution agreement with SES for all its channels and relies on MX1 for technical services

LUXEMBOURG-Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- German viewers will continue to have access to all ProSiebenSat.1 free-to-air channels in SD quality via SES’s prime orbital slot at 19.2 degrees East.

Under the multi-year renewal agreement, SES will provide satellite capacity for the unencrypted transmission of the channels ProSieben, Sat.1, kabel eins, sixx, Sat.1 GOLD, ProSieben MAXX and kabel eins Doku, as well as the regional programmes of Sat.1 in Bavaria and North Rhine-Westphalia. The contract also includes additional technical services from the SES’s subsidiary MX1, a global solution provider of media services.

“In Germany, 46% of TV viewers receive our programmes via satellite – and increasingly also in the best HD quality via the SES platform HD+. With this n ... Read more »

 Digital Transformation Barometer research identifies positive impact of digitally literate leaders and examines hype vs. reality of emerging technologies 

ROLLING MEADOWS, Ill.-Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Only half (53 percent) of surveyed business technology professionals believe their organization’s leadership is digitally literate, according to ISACA’s new Digital Transformation Barometer research. The other 47 percent either don’t think their business leaders have a solid understanding of technology and its impacts, or are unsure. In addition, the global research study tempers the hype surrounding some emerging technologies, as respondents reality checked which technologies will be rapidly adopted, cautiously tested or parked for future consideration in the digital transformation crusade.

The findings were released today and paint a concerning portrait for the progress to date, and future of ... Read more »

The SET initiative invites start-ups around the world to apply

BONN, Germany & BERLIN & LONDON -Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- SET, an initiative by the Deutsche Energie-Agentur – the German Energy Agency (dena) – in cooperation with strategic partner, the World Energy Council, has launched the second round of the international award ‘Start Up Energy Transition’ (SET) during the annual UN Climate Change Conference (COP 23) in Bonn, Germany. Young companies and innovation projects around the world are invited to apply. The goal is to identify the most promising start-ups working on the energy transition and climate protection. Applications are welcome until 31 January 2018 at www.startup-energy-transition.com.

The award forms part of the SET initiative, which also comprises the annual SET Tech Festival and a rapidly growing network. In the current round, the initiative is supported by the Governme ... Read more »

ATLANTA -Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Huber Engineered Materials (HEM), a leading global producer of specialty performance ingredients for industrial and consumer products and a division of the J.M. Huber Corporation (Huber), announces that Dan Krawczyk has been appointed HEM President, effective Nov. 1, 2017. Krawczyk remains a member of the HEM Board of Directors and Huber Management Council.

Before becoming the President of HEM, Krawczyk served as Huber’s Executive Vice President (EVP) of Strategy & Corporate Development since 2013. He brings more than 20 years of experience in industrial and consumer products, including expertise in financial management, strategy, corporate development, marketing and operations to his new leadership role. A native of the Detroit area, Krawczyk earned an MBA as well as an MS and BS in Electrical Engineering from the University of Michigan.

Prior to joining Huber, K ... Read more »

INGELHEIM, Germany-Wednesday, November 15th 2017 [ AETOS Wire ]

    Dual therapy with dabigatran consistently favourable across key sub-groups in atrial fibrillation patients following PCI with stent placement
    Benefits shown in sub-group analyses were consistent with overall results of the trial
    Data presented at AHA Scientific Sessions 2017 reinforce safety benefits of dabigatran

(BUSINESS WIRE)-- Boehringer Ingelheim has shared sub-analyses from the RE-DUAL PCI™ clinical trial at the AHA Scientific Sessions 2017 in Anaheim, California. RE-DUAL PCI™ investigated different treatment approaches in patients with non-valvular atrial fibrillation (AF) following percutaneous coronary intervention (PCI) with stent placement. Anticoagulation using dual therapy with dabigatran etexilate (marketed as Pradaxa®) and a single antiplatelet without aspirin was compared to triple therapy ... Read more »

COLOMBES, France -Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- IDEMIA, the global leader in trusted identities for an increasingly digital world, provides a complete passenger processing biometric system at Changi Airport Terminal 4 in Singapore. The terminal was opened on October 31, 2017.

IDEMIA (formerly known as OT-Morpho) strives to enable people to communicate, connect, vote, move around and travel safely, while also giving end-users unparalleled convenience.

In September 2015, Changi Airport – ranked world top airport for the fifth year in a row1 - selected IDEMIA to provide biometric identification and authentication services as passengers pass through the airport’s most innovative terminal.

The chosen solution based on IDEMIA’s MorphoPass Airport Solution provides automated passenger ID checks using facial recognition at all departure control points. The system includes a centralized platform ... Read more »

SHENZHEN, China-Wednesday, November 15th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- The 19th China Hi-Tech Fair (CHTF), known as China’s No. 1 technology show, will take place from November 16 to 21 at Shenzhen Convention and Exhibition Center. Themed with “Innovation-Driven Development and Supply Quality Upgrade” this year, the fair will cover energy conservation & environment protection, new generation IT, biology, high-end equipment manufacturing, new energy, new materials, and new energy vehicles. The following are 8 highlights of CHTF 2017.

1. AI

AI products will be featured in all exhibition areas. Exhibitors will bring their newest AI products and announce global/domestic launches at CHTF.

2. “One Belt, One Road” cooperation

The international pavilion and “Belt & Road” area will see exhibitors from over 30 countries and international organizations including Argentina, Czech, Germany, Greece, ... Read more »

INGELHEIM, Germany-Wednesday, November 15th 2017 [ AETOS Wire ]

    Dual therapy with dabigatran consistently favourable across key sub-groups in atrial fibrillation patients following PCI with stent placement
    Benefits shown in sub-group analyses were consistent with overall results of the trial
    Data presented at AHA Scientific Sessions 2017 reinforce safety benefits of dabigatran

(BUSINESS WIRE)-- Boehringer Ingelheim has shared sub-analyses from the RE-DUAL PCI™ clinical trial at the AHA Scientific Sessions 2017 in Anaheim, California. RE-DUAL PCI™ investigated different treatment approaches in patients with non-valvular atrial fibrillation (AF) following percutaneous coronary intervention (PCI) with stent placement. Anticoagulation using dual therapy with dabigatran etexilate (marketed as Pradaxa®) and a single antiplatelet without aspirin was compared to triple therapy with warfarin. ... Read more »

Faslodex (Fulvestrant) Receives EU Approval for the Treatment of Hormone Receptor-Positive Advanced Breast Cancer in Combination with Palbociclib¹

^{CAMBRIDGE, England-Tuesday, November 14th 2017 [ AETOS Wire ]}

^{First EU approval for fulvestrant in combination with a CDK4/6 inhibitor}

^{Fulvestrant in combination with palbociclib showed progression-free survival (PFS) improvement of 4.9 months compared to combination of fulvestrant with placebo2}

^{(BUSINESS WIRE)-- AstraZeneca today announced that the European Commission (EC) has approved a new indication for Faslodex (fulvestrant) in combination with a CDK4/6 inhibitor, palbociclib, for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer in w ... Read more »}

INGELHEIM, Germany -Tuesday, November 14th 2017 [ AETOS Wire ]

    Additional analyses of patients in diverse emergency settings confirm that idarucizumab immediately reverses the anticoagulant effect of dabigatran in patients in emergency settings1,2
    Sub-analyses from RE-VERSE AD™, the largest study to investigate a reversal agent for a non-vitamin K antagonist oral anticoagulant (NOAC), presented at the American Heart Association Scientific Sessions 20171,2

(BUSINESS WIRE)-- Boehringer Ingelheim announced results from two sub-analyses of the phase III RE-VERSE AD™ study.1,2 The sub-analyses evaluated the safety and efficacy of idarucizumab (marketed as Praxbind®) in reversing the anticoagulant effect of dabigatran etexilate (marketed as Pradaxa®) in patients in diverse emergency situations. These include those with acute bleeding or requiring an urgent surgery or procedure, such as an orthopedic, vascular ... Read more »